Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
3,4-Dihydroxyphenyl-l-alanine (l-DOPA)-induced dyskinesia is associated with molecular and synaptic plasticity in the basal ganglia, but the occurrence of structural remodeling through cell genesis has not been explored. In this study, rats with 6-hydroxydopamine lesions received injections of the thymidine analog 5-bromo-2′-deoxyuridine (BrdU) concomitantly with l-DOPA for 2 weeks. A large number of BrdU-positive cells were found in the striatum and its output structures (globus pallidus, entopeduncular nucleus, and substantia nigra pars reticulata) in l-DOPA-treated rats that had developed dyskinesia. The vast majority (60–80%) of the newborn cells stained positively for endothelial markers. This endothelial proliferation was associated with an upregulation of immature endothelial markers (nestin) and a downregulation of endothelial barrier antigen on blood vessel walls. In addition, dyskinetic rats exhibited a significant increase in total blood vessel length and a visible extravasation of serum albumin in the two structures in which endothelial proliferation was most pronounced (substantia nigra pars reticulata and entopeduncular nucleus). The present study provides the first evidence of angiogenesis and blood–brain barrier dysfunction in an experimental model of l-DOPA-induced dyskinesia. These microvascular changes are likely to affect the kinetics of l-DOPA entry into the brain, favoring the occurrence of motor complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Indeed, Ox42 immunohistochemistry (Kreutzberg, 1996; Sugama et al., 2003) revealed no activation of resting microglial cells, and no dying neurons were detected by Fluoro-Jade histochemistry in the basal ganglia of L-DOPA-treated animals (data not shown).”
BackgroundNeuronal replacement from endogenous precursors in the adult brain after stroke
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., & Lindvall, O. (2002) · Nature Medicine · doi:10.1038/nm747 · Cited by 2,799 · cited 3×
“, the subventricular zone of the lateral ventricle and the dentate gyrus of the hippocampus) in experimental models of stroke (Arvidsson et al., 2002; Komitova et al., 2002, 2005), epileptic seizures (Bengzon et al.”
BackgroundInfluentialAn acidic protein isolated from fibrous astrocytes
Eng, L. F., Vanderhaeghen, J. J., Bignami, A., & Gerstl, B. (1971) · Brain Research · doi:10.1016/0006-8993(71)90668-8 · Cited by 1,230 · cited 2×
“As markers for glial cells, we used GFAP, which mainly labels postmitotic astrocytes (Eng et al., 1971; Bignami et al., 1972; Lee et al., 2000), and the chondroitin sulfate proteoglycan NG2, which labels a subpopulation of glial cells with proliferative properties that are part of the oligodendrocyte lineage (Dawson e…”
MethodBlack, J. E., Isaacs, K. R., Anderson, B. J., Alcantara, A. A., & Greenough, W. T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5568 · Cited by 1,161
Dawson, M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00210-0 · Cited by 927 · cited 4×
“Constitutive proliferation of glial progenitor cells occurs through adulthood in both white and gray matter and is enhanced under a variety of pathophysiological conditions (Chang et al., 2000; Mao and Wang, 2001; Dawson et al., 2003; Wennstrom et al., 2003).”
BackgroundResultInfluentialLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821 · cited 4×
“…L-DOPA-induced dyskinesia, including altered expression of genes and proteins in the striatum (Cenci et al., 1998; Andersson et al., 1999; Calon et al., 2000; Tel et al., 2002; Henry et al., 2003; Konradi et al., 2004), and abnormal potentiation of corticostriatal synapses (Picconi et al., 2003).”
BackgroundInfluentialSelf-citationBlood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Swain, R. A., Harris, A. B., Wiener, E. C., Dutka, M. V., Morris, H. D., Theien, B. E., Konda, S., Engberg, K., Lauterbur, P. C., & Greenough, W. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00664-4 · Cited by 655
Amino acid assignment to one of three blood-brain barrier amino acid carriers
Oldendorf, W., & Szabo, J. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.230.1.94 · Cited by 594 · cited 2×
“In particular, newly born and leaky microvessels may alter the kinetics of L-DOPA entry into the brain, which is critically regulated at the level of the brain endothelium (Wade and Katzman, 1975; Oldendorf and Szabo, 1976; Hawkins et al., 2005) and is greatly limited by the BBB (Hardman et al.”
BackgroundRegulation of adult neurogenesis by antidepressant treatment
Duman, R. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00358-x · Cited by 463 · cited 2×
“, 1997), and electroconvulsive and antidepressant therapy (Duman et al., 2001; Hellsten et al., 2002).”
Background
Cited by
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Neurovascular signalling defects in neurodegeneration
Zacchigna, S., Lambrechts, D., & Carmeliet, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2336 · Cited by 345
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
Lindgren, H. S., Andersson, D. R., Lagerkvist, S., Nissbrandt, H., & Cenci, M. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06556.x · Cited by 263
Self-citation
Metadata
- Authors
- Westin, J. E., Lindgren, H. S., Gardi, J., Nyengaard, J. R., Brundin, P., Mohapel, P., & Cenci, M. A.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-09-13
- Volume
- 26
- Issue
- 37
- Pages
- 9448-9461
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2136632794
- Cited by
- 129
- References
- 12
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia. https://app.cochat.ai/papers/10.1523/jneurosci.0944-06.2006
- The paper
- Westin, J. E., Lindgren, H. S., Gardi, J., Nyengaard, J. R., Brundin, P., Mohapel, P., & Cenci, M. A. (2006). Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0944-06.2006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.